Legal Representation
Attorney
Gregory J. Chinlund
USPTO Deadlines
Next Deadline
1735 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-07)
Due Date
May 07, 2030
Grace Period Ends
November 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 7, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
May 7, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Mar 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 20, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 1, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 1, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 31, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 12, 2024 | OTHE | I | CASE RETURNED TO EXAMINATION | Loading... |
Jan 12, 2024 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
Dec 8, 2023 | PCBG | O | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | Loading... |
Dec 8, 2023 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Dec 7, 2023 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
Nov 13, 2023 | TPAD | I | TEAS PETITION TO AMEND BASIS RECEIVED | Loading... |
Nov 9, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Nov 9, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Nov 9, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Nov 9, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Nov 9, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Nov 9, 2023 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
Nov 9, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Nov 7, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 12, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 12, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 23, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 8, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jul 26, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jul 26, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 26, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jul 26, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 13, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jun 13, 2023 | CEPE | I | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | Loading... |
Jun 7, 2023 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
Jun 7, 2023 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
Jun 7, 2023 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
May 20, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 7, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 20, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Biological preparations for the treatment of cancer for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; diagnostic preparations for medical purposes; dietary supplements for human beings; Dietetic foods and beverages adapted for medical use; adjuvants for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Medicinal preparations for the mouth to be applied in the form of capsules; Pharmaceutical and biological preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders and cancer for medical purposes
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICINE"